Insider filing · SYRE
Michael Thomas Henderson
Director
profile →
Spyre Therapeutics, Inc.
SYRE · Healthcare · 32 filings in 24 months
ticker →
Michael Thomas Henderson sold $2.0M of Spyre Therapeutics (SYRE)
Executed Jun 22, disclosed Jun 23, 1 day later.
Value, as filed
$2.0M
20,000 sh × $100.00
Executed
Jun 22
the trade date, as filed
Disclosed
Jun 23
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MHMichael Thomas Henderson (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $10.6M of APGE (80,000 sh × $132.54, as filed), executed Jun 22.
The name
SYREHealthcare · Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael Thomas Henderson in SYRE
SYRESALE
Spyre Therapeutics, Inc.
$6.0M80,000 sh across 4 lots
Exec May 8
Filed May 8 · 5:30 PM ET